SOURCE: Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc.

June 28, 2011 09:00 ET

Therapeutic Solutions International, Inc. Signs Distribution Agreements in Hong Kong and Singapore

SAN DIEGO, CA--(Marketwire - Jun 28, 2011) - Therapeutic Solutions International, Inc. (OTCQB: TSOI) (PINKSHEETS: TSOI), the only manufacturer of the chairside NTI Tension Suppression System (NTI-tss) that has helped countless patients prevent debilitating migraine and tension headache pain, announced today the signing of a sales and distribution agreement with TWL Ltd., a dental supply company headquartered in Hong Kong and Cross Protection PTE, Ltd., a dental supply company headquartered in Singapore.

"We are very pleased to sign these initial sales agreements in Asia," stated Tim Dixon, President of TSI. "As we continue to achieve our implementation to market this patented technology worldwide, we expect other Asian countries to follow suit shortly. The availability of the NTI Tension Suppression System will allow dentists throughout Hong Kong and Singapore the ability to provide our unique migraine prevention product to their patients."

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc. is a company that has developed, is producing and currently marketing the FDA Approved NTI Tension Suppression System for the prevention of medically diagnosed migraine pain. The NTI dental device is the most cost effective, non-drug method of migraine prevention on the market today. TSI currently has strong International Patent Protection in those countries we are marketing our products into. TSI has several important websites to disseminate information and market their products. Our patient education site located at www.headacheprevention.com, and our corporate website for TSI is www.therapeuticsolutionsint.com.

Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, termination of contracts or agreements, technological obsolescence of our products, technical problems with our research and products, price increases for supplies and components, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.

Contact Information

  • For more information please contact:

    Jens Dalsgaard
    President
    Constellation Asset Advisors, Inc
    (415) 524-8500
    info@constellationaa.com